Health ❯ Mental Health ❯ Depression

Major Depressive Disorder

Clinical Trials Treatment Options Transcranial Direct Current Stimulation Psychedelic Treatment Treatment Methods Preventive Measures Gut Microbiome Psychedelic Treatments Fatigue Relapse Prevention Statistics Pharmaceuticals Impact on Behavior Genetic Factors Anhedonia Reelin Therapeutics Clinical Development Brain Aging Anti-depressant Efficacy Youth Neural Signaling Pathways Pharmaceutical Treatments Treatment Mechanisms Diagnosis and Treatment Women's Health High-Salt Diet

Smartphone Game Identifies Anhedonia and Flags Depression in Three Minutes

Researchers say the brief, low-cost test could enable remote screening and more tailored care if larger clinical validation confirms the findings.

BullFrog AI Strikes Top-5 Pharma Deal To Find Depression Drug Targets

Study Links Depression Fatigue to Distinct Cellular Energy Pattern in Brain and Blood

Single IV DMT Dose With Therapy Shows Rapid, Lasting Antidepressant Effect in Phase IIa Trial

Single IV Dose of DMT Shows Rapid, Lasting Antidepressant Effects in Small Trial

JAMA Psychiatry Study Finds Wearable Sleep-Activity Data Can Forecast Depression Relapse

FDA Approves J&J’s Caplyta for Major Depressive Disorder

Single Reelin Injection Restores Gut Protein After Stress in Preclinical UVic Study

Soft Drinks Linked to Depression in Women, Study Finds a Microbiome Signal

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

New Studies Highlight Ezogabine’s Potential to Redefine Depression Treatment